| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-555 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6421 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e67320ea129df528811eeda4cb59229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc2e541240a2f46a61f9ec20cffa6af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac54978f20c6a698f775d454b4ee32ae |
| publicationDate |
2015-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015033831-A1 |
| titleOfInvention |
Dpp-4-targeting vaccine for treating diabetes |
| abstract |
Provided are: a vaccine for preventing or treating diabetes capable of inducing a neutralization antibody against DPP-4, wherein an amino acid sequence represented by SEQ ID NO:2, a polypeptide containing an amino acid sequence corresponding to SEQ ID NO:2 in a non-human mammal, etc. is used as an immunogen; and a prophylactic or therapeutic agent for diabetes that comprises a DPP-4 neutralizing antibody capable of recognizing a partial amino acid sequence of DPP-4 as described above. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017164409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4194007-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180123064-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980876-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108883166-A |
| priorityDate |
2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |